Can Fecal Calprotectin Be Used as a Biomarker of Non-alcoholic Fatty Liver Disease In Obese Adolescents?

NCT06229184 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Obesity, Childhood
NAFLD

Interventions

DIAGNOSTIC_TEST: Fecal Calprotectin Test

Sponsor

Sisli Hamidiye Etfal Training and Research Hospital